“…Others have observed later expression of the memory cell phenotype by the vast majority of PHA-stimulated T cells from healthy individuals [11,13,14], Changes were not due to increased cell proliferation, and consistent with this, conversion into the memory cell phenotype has not been found to be necessarily correlated with proliferation [31], Increased expression of adhesion molecules might lead to facilitated localization of memory T cells to the inflamed tissue [32], In this regard, Pitzalis et al [33] have demonstrated the preponderance of CD4+CD29+UCHL1 + cells in the rheumatic joint, and in other inflammatory lesions [34], In addition, CD29+ memory T cells have been shown to have a greater ability to adhere to vascular endothelium than their CD29c ounterpart [35], Therefore, enhanced expression of CD29 and other adhesion molecules might lead to accumulation of CD4+ memory cells at tissue sites, and could result in depletion ofthis cell subset in the peripheral blood of patients with MCTD, Interestingly, activated T cells and a high proportion of CD4+ cells have been detected in the infiltrated skin of PSS patients with recent onset of disease [36], It remains to be clarified whether the imbalance of CD4+ cell subsets might lead to reduced suppressor T cell function in patients with MCTD, Similar to Melendro et al [7], we observed diminished numbers of CD8+ cells in MCTD, Data obtained earlier by Alarcjon-Segovia & Ruiz-Arguelles [6] suggest that anti-RNP antibodies might cause deletion of suppressor T cells. It might be considered that altered responsiveness and lymphokine secretion of CD4+ cell subsets exert indirect effects on CDS"*" cells by enhancing B cell activity.…”